Substrate binding and formation of an occluded state in the leucine transporter

Biophysical Journal

Volumn 94, Issue 5, 2008, Pages 1600-1612

  Celik, Leyla ^a,b   Schiøtt, Birgit ^b   Tajkhorshid, Emad ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSPORTER; ARGININE; ASPARTIC ACID; ION; LEUCINE; PHENYLALANINE; SODIUM; TYROSINE;

ARTICLE; BINDING SITE; CHEMISTRY; COMPUTER SIMULATION; ENZYME SPECIFICITY; EXTRACELLULAR SPACE; METABOLISM; PROTEIN CONFORMATION; TRANSPORT AT THE CELLULAR LEVEL; X RAY CRYSTALLOGRAPHY;

AMINO ACID TRANSPORT SYSTEMS; ARGININE; ASPARTIC ACID; BINDING SITES; BIOLOGICAL TRANSPORT; COMPUTER SIMULATION; CRYSTALLOGRAPHY, X-RAY; EXTRACELLULAR SPACE; IONS; LEUCINE; PHENYLALANINE; PROTEIN CONFORMATION; SODIUM; SUBSTRATE SPECIFICITY; TYROSINE;

EID: 41449093586     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1529/biophysj.107.117580     Document Type: Article

References (72)

1. Torres, G. E., R. R. Gainetdinov, and M. G. Caron. 2003. Plasma membrane monoamine transporters: structure, regulation and function. Nat. Rev. Neurosci. 4:13-25.
2. Hahn, M. K., and R. D. Blakely. 2002. Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders. Pharmacogenomics J. 2:217-235.
3. Masson, J., C. Sagne, M. Hamon, and S. E. Mestikawy. 1999. Neurotransmitter transporters in the central nervous system. Pharmacol. Rev. 51:439-464.
4. Owens, M. J., and C. B. Nemeroff. 1994. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin. Chem. 40:288-295.
5. Rudnick, G. 2002. Mechanisms of biogenic amine neurotransmitter transporters. In Neurotransmitter transporters: structure, function, and regulation. 2nd edition. M. E. A. Reith, editor. Humana Press, Totowa, NJ. 25-52.
6. Ravna, A. W., I. Sylte, and S. G. Dahl. 2003. Molecular model of the neural dopamine transporter. J. Comput. Aided Mol. Des. 17:367-382.
7. Ravna, A. W., I. Sylte, and S. G. Dahl. 2003. Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters. J. Pharmacol. Exp. Ther. 307:34-41.
8. Dahl, S. G., I. Sylte, and A. W. Ravna. 2004. Structures and models of transporter proteins. J. Pharmacol. Exp. Ther. 309:853-860.
9. Ravna, A. W., I. Sylte, K. Kristiansen, and S. G. Dahl. 2006. Putative drug binding conformations of monoamine transporters. Bioorg. Med. Chem. 14:666-675.
10. Gundertofte, K., K. P. B0ges0, and T. Liljefors. 1997. A stereoselective pharmacophoric model of the serotonin reuptake site. In Computer-assisted lead finding and optimization. H. vad de Waterbeemd, B. Testa, and G. Folkers, editors. Verlag Helvetica Chimica Acta, Basel.
11. Pratuangdejkul, J., B. Schneidier, P. Jaudon, V. Rosilio, E. Baudoin, S. Loric, M. Conti, J. M. Launay, and P. Manivet. 2005. Definition of an uptake pharmacophore of the serotonin transporter through 3D-QSAR analysis. Curr. Med. Chem. 12:2393-2410.
12. Hoffman, B. T., T. Kopajtic, J. L. Katz, and A. H. Newman. 2000. 2D QSAR modeling and preliminary database searching for dopamine transporter inhibitors using genetic algorithm variable selection of molconn Z descriptors. J. Med. Chem. 43:4151-4159.
13. Kulkarni, S. S., A. H. Newman, and W. J. Houlihan. 2002. Three-dimensional quantitative structure-activity relationships of mazindol analogues at the dopamine transporter. J. Med. Chem. 45:4119-4127.
14. Christensen, H., S. Boye, J. Thinggaard, S. Sinning, O. Wiborg, B. Schiøtt, and M. Bols. 2007. QSAR studies and pharmacophore identification for arylsubstituted cycloalkenecarboxylic acid methyl esters with affinity for the human dopamine transporter. Bioorg. Med. Chem. 15:5262-5274.
15. --dependent neurotransmitter transporters. Nature. 437:215-223.
16. Singh, S. K., A. Yamashita, and E. Gouaux. 2007. Antidepressant binding site in a bacterial homologue of neurotransmitter transporters. Nature. 448:952-956.
17. Zhou, Z., J. Zhen, N. K. Karpowich, R. M. Goetz, C. J. Law, M. E. A. Reith, and D.-N. Wang. 2007. LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake. Science. 317:1390-1393.
18. + symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function. Mol. Pharmacol. 70: 1630-1642.
19. Aa template. Bioorg. Med. Chem. Lett. 16: 5594-5597.
20. Jørgensen, A. M., L. Tagmose, A. M. M. J0rgensen, S. Topiol, M. Sabio, K. Gundertofte, K. P. Bøgesø, and G. H. Peters. 2007. Homology modeling of the serotonin transporter: Insights into the primary escitalopram-binding site. ChemMedChem. 2:815-826.
21. -- dependent neurotransmitter transporters in a membrane-aqueous system. ChemMedChem. 2:827-840.
22. Paczkowski, F. A., I. A. Sharpe, S. Dutertre, and R. J. Lewis. 2007. Chi-conopeptide and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model. J. Biol. Chem. 282:17837-17844.
23. Huang, X., and C. Zhan. 2007. How dopamine transporter interacts with dopamine: insights from molecular modeling and simulation. Biophys. J. 93:3627-3639.
24. Aa leucine transporter as a template. Proteins Struct. Funct. Bioinformatics. 70:1033-1046.
25. Yernool, D., O. Boudker, Y. Jin, and E. Gouaux. 2004. Structure of a glutamate transporter homologue from pyrococcus horikoshi. Nature. 431:811-818.
26. Boudker, O., R. M. Ryan, D. Yernool, K. Shimamoto, and E. Gouaux. 2007. Coupling substrate and ion binding to extracellular gate of a sodium-dependent aspartate transporter. Nature. 445:387-393.
27. + conduction and selectivity. Science. 280:69-77.
28. + antiporter and insights into mechanism of action and regulation by pH. Nature. 435:1197-1202.
29. Sui, H., B. Han, J. K. Lee, P. Walian, and B. K. Jap. 2001. Structural basis of water-specific transport through the AQP1 water channel. Nature. 414:872-878.
30. Pantanowitz, S., A. Bendahan, and B. I. Kanner. 1993. Only one ofthe charged amino acids located in the transmembrane a-helices of the γ-aminobutyric acid transporter (subtype A) is essential for its activity. J. Biol. Chem. 268:3222-3225.
31. Cao, Y., M. Li, S. Mager, and H. A. Lester. 1998. Amino acid residues that control pH modulation of transport-associated current in mammalian serotonin transporters. J. Neurosci. 18:7739-7749.
32. Jardetzky, O. 1966. Simple allosteric model for membrane pumps. Nature. 211:969-970.
33. Jones, S. R., J. D. Joseph, L. S. Barak, M. G. Caron, and R. M. Wightman. 1999. Dopamine neuronal transport kinetics and effects of amphetamine. J. Neurochem. 73:2406-2414.
34. Schenk, J. 2002. The functioning neuronal transporter for dopamine: kinetic mechanisms and effects of amphetamines, cocaine and methylphenidate. Prog. Drug Res. 59:111-131.
35. Rudnick, G. 2006. Serotonin transporters-structure and function. J. Membr. Biol. 213:101-110.
36. Adcock, S. A., and J. A. McCammon. 2006. Molecular dynamics: Survey of methods for simulating the activity of proteins. Chem. Rev. 105:1589-1615.
37. Karplus, M., and J. Kuriyan. 2005. Chemical theory and computation special feature: molecular dynamics and protein function. Proc. Natl. Acad. Sci. USA. 102:6679-6685.
38. Tajkhorshid, E., J. Cohen, A. Aksimentiev, M. Sotomayor, and K. Schulten. 2005. Towards understanding membrane channels. In Bacterial ion channels and their eukaryotic homologues. B. Martinac and A. Kubalski, editors. American Society of Microbiology Press, Washington, DC. 153-190.
39. Gumbart, J. C., Y. Wang, A. Aksimentiev, E. Tajkhorshid, and K. Schulten. 2005. Molecular dynamics simulations of proteins in lipid bilayers. Curr. Opin. Struct. Biol. 15:423-431.
40. Tajkhorshid, E., A. Aksimentiev, I. Balabin, M. Gao, B. Isralewitz, J. C. Phillips, F. Zhu, and K. Schulten. 2003. Large scale simulation of protein mechanics and function. Adv. Protein Chem. 66:195-247.
41. Celik, L., J. D. D. Lund, and B. Schiøtt. 2007. Conformational dynamics of the estrogen receptor α: molecular dynamics simulations of the influence of binding site structure on protein dynamics. Biochemistry. 46:1743-1758.
42. Lindorff-Larsen, K., R. B. Best, M. A. DePristo, C. M. Dobson, and M. Vendruscolo. 2005. Simultaneous determination of protein structure and dynamics. Nature. 433:128-132.
43. Hornak, V., A. Okur, R. C. Rizzo, and C. Simmerling. 2006. HIV-1 protease flaps spontaneously open and reclose in molecular dynamics simulations. Proc. Natl. Acad. Sci. USA. 103:915-920.
44. Hornak, V., A. Okur, R. C. Rizzo, and C. Simmerling. 2006. HIV-1 protease flaps spontaneously close to the correct structure in simulations following manual placement of an inhibitor into the open state. J. Am. Chem. Soc. 128:2812-2813.
45. Yin, Y., M. Ø. Jensen, E. Tajkhorshid, and K. Schulten. 2006. Sugar binding and protein conformational changes in lactose permease. Biophys. J. 91:3972-3985.
46. Israelewitz, B., M. Gao, and K. Schulten. 2001. Steered molecular dynamics and mechanical functions of proteins. Curr. Opin. Struct. Biol. 11:224-230.
47. Gao, M., M. Sotomayor, E. Villa, E. Lee, and K. Schulten. 2006. Molecular mechanisms of cellular mechanics. Phys.Chem. Chem.Phys. 8: 3692-3706.
48. Sotomayor, M., and K. Schulten. 2007. Single-molecule experiments in vitro and in silico. Science. 316:1144-1148.
49. Jensen, M. Ø., S. Park, E. Tajkhorshid, and K. Schulten. 2002. Energetics of glycerol conduction through aquaglyceroporin GlpF. Proc. Natl. Acad. Sci. USA. 99:6731-6736.
50. Wang, Y., K. Schulten, and E. Tajkhorshid. 2005. What makes an aquaporin a glycerol channel? A comparative study of AqpZ and GlpF. Structure. 13:1107-1118.
51. Jensen, M. Ø., Y. Yin, E. Tajkhorshid, and K. Schulten. 2007. Sugar transport across lactose permease probed by steered molecular dynamics. Biophys. J. 93:92-102.
52. Gumbart, J. C., M. C. Wiener, and E. Tajkhorshid. 2007. Action at a distance: mechanics of force propagation in TonB-dependent outer membrane transport. Biophys. J. 93:496-504.
53. Gao, M., D. Craig, O. Lequin, I. Campbell, V. Vogel, and K. Schulten. 2003. Structure and functional significance of mechanically unfolded fibronectin type intermediates. Proc. Natl. Acad. Sci. USA. 100: 14784-14789.
54. Marszalek, P. E., H. Lu, H. Li, M. Carrion-Vazquez, A. F. Oberhauser, K. Schulten, and J. M. Fernandez. 1999. Mechanical unfolding intermediates in titin modules. Nature. 402:100-103.
55. + antiporting. Science. 317:799-803.
56. Berman, H. M., J. Westbrook, Z. Feng, G. Gilliland, T. N. Bhat, H. Weissig, I. N. Shindyalov, and P. E. Bourne. 2000. The protein data bank. Nucleic Acids Res. 28:235-242.
57. Humphrey, W., A. Dalke, and K. Schulten. 1996. VMD: visual molecular dynamics. J. Mol. Graph. 14:33-38.
58. MacKerell, A. D. J., D. Bashford, M. Bellott, R. L. Dunbrack, Jr., J. D. Evanseck, M. J. Field, S. Fischer, J. Gao, H. Guo, S. Ha, D. Joseph- McCarthy, L. Kuchnir, K. Kuczera, F. T. K. Lau, C. Mattos, S. Michnick, T. Ngo, D. T. Nguyen, B. Prodhorn, W. E. Reiher III, B. Roux, M. Schlenkrich, J. C. Smith, R. Stote, J. Straub, M. Watanabe, J. Wiórkiewicz-Kuczera, D. Yin, and M. Karplus. 1998. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem. B. 102:3586-3616.
59. MacKerell, A. D. J. 2001.Atomistic models and force fields. In Computational biochemistry and biophysics. O. M. Becker, A. D. J. MacKerell, B. Roux, and M. Watanabe, editors. Marcel Dekker, New York. 7-38.
60. MacKerell, A. D. J. 2004. Empirical force fields for biological macro-molecules: Overview and issues. J. Comput. Chem. 25:1584-1604.
61. MacKerell, A. D., M. Feig, and C. L. Brooks III. 2004. Extending the treatment of backbone energetics in protein force fields: limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations. J. Comput. Chem. 25:1400-1415.
62. Kocabas, A. M., G. Rudnick, and F. Kilic. 2003. Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters. J. Neurochem. 85:1513-1520.
63. Just, H., H. H. Sitte, J. A. Schmid, M. Freissmuth, and O. Kudlacek. 2004. Identification of an additional interaction domain in transmembrane domains 11 and 12 that supports oligomer formation in the human serotonin transporter. J. Biol. Chem. 279:6650-6657.
64. Jones, T. A., J.-Y. Zou, S. W. Cowan, and M. Kjeldgaard. 1991.Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A. 47:110-119.
65. Onufriev, A., D. A. Case, and G. M. Ullmann. 2001. A novel view of pH titration in biomolecules. Biochemistry. 40:3413-3419.
66. Kale, L., R. Skeel, M. Bhandakar, R. Brunner, A. Gursoy, N. Krawetz, J. Phillips, A. Shinozaki, K. Varadarajan, and K. Schulten. 1999. NAMD2: greater scalability for parallel molecular dynamics. J. Comput. Phys. 151:283-312.
67. Phillips, J. C., R. Braun, W. Wang, J. Gumbart, E. Tajkhorshid, E. Villa, C. Chipot, R. D. Skeel, L. Kalé, and K. Schulten. 2005. Scalable molecular dynamics with NAMD. J. Comput. Chem. 26: 1781-1802.
68. Darden, T., D. York, and L. Pedersen. 1993. Particle mesh Ewald: An N×log(N) method for Ewald sums in large systems. J. Chem. Phys. 98: 10089-10092.
69. Feller, S. E., Y. Zhang, R. W. Pastor, and B. R. Brooks. 1995. Constant pressure molecular dynamics simulation: The langevin piston method. J. Chem. Phys. 103:4613-4621.
70. Park, S., F. Khalili-Araghi, E. Tajkhorshid, and K. Schulten. 2003. Free energy calculation from steered molecular dynamics simulations using Jarzyinski's equality. J. Chem. Phys. 119:3559-3566.
71. Guptaroy, B., M. Zhang, F. Binda, E. Bowton, L. Johnson, A. Galli, J. Javitch, and M. Gnegy. 2006. An N-terminal mutation of the dopamine transporter results in an efflux promoting conformation. Program No. 35.13. 2006 Neuroscience meeting planner. Society for Neuroscience, Atlanta, GA. http://www.sfn.org/am2006/.
72. Celik, L., S. Sinning, K. Severinsen, C. G. Hansen, M. S. Møller, M. Bols, O. Wiborg, and B. Schiøtt. 2008. Binding of serotonin to the human serotonin transporter. Molecular modelling and experimental validation. J. Am. Chem. Soc. In press.